These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16298454)

  • 1. Micro- and nanoparticulates.
    Moshfeghi AA; Peyman GA
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2047-52. PubMed ID: 16298454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular sustained drug delivery using implantable polymeric devices.
    Yasukawa T; Ogura Y; Sakurai E; Tabata Y; Kimura H
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2033-46. PubMed ID: 16263193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery methods for posterior segment disease.
    Hsu J
    Curr Opin Ophthalmol; 2007 May; 18(3):235-9. PubMed ID: 17435432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano and microparticles as controlled drug delivery devices.
    Ravi Kumar MN
    J Pharm Pharm Sci; 2000; 3(2):234-58. PubMed ID: 10994037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel drug delivery systems for retinal diseases. A review.
    Lee SS; Robinson MR
    Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment of age-related macular degeneration.
    Zarbin M; Szirth B
    Optom Vis Sci; 2007 Jul; 84(7):559-72. PubMed ID: 17632299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
    Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
    Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F; Lafuma A; Berdeaux G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of an anti-infection nano-hydroxypatite drug delivery microsphere and its drug-release in vitro].
    Wang YF; Jin AM; Wei K; Wang XD; Tang SH; Min SX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):754-6. PubMed ID: 16793592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
    Alexander SL; Linde-Zwirble WT; Werther W; Depperschmidt EE; Wilson LJ; Palanki R; Saroj N; Butterworth SL; Ianchulev T
    Ophthalmology; 2007 Dec; 114(12):2174-8. PubMed ID: 18054636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Pruente C
    Prog Retin Eye Res; 2007 Jul; 26(4):437-51. PubMed ID: 17512238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copolymeric nanofilm platform for controlled and localized therapeutic delivery.
    Chow EK; Pierstorff E; Cheng G; Ho D
    ACS Nano; 2008 Jan; 2(1):33-40. PubMed ID: 19206545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of age-related macular degeneration.
    Ting AY; Lee TK; MacDonald IM
    Curr Opin Ophthalmol; 2009 Sep; 20(5):369-76. PubMed ID: 19587596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranibizumab for the treatment of neovascular AMD.
    Kaiser PK; Do DV
    Int J Clin Pract; 2007 Mar; 61(3):501-9. PubMed ID: 17313620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA; Rosenfeld PJ
    Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL; Yu F
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of retinal diseases with VEGF antagonists.
    Schlingemann RO; Witmer AN
    Prog Brain Res; 2009; 175():253-67. PubMed ID: 19660661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery strategies for combination ophthalmic treatments.
    Kuppermann BD
    Retina; 2009 Jun; 29(6 Suppl):S24-6. PubMed ID: 19553793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.